Hemostemix.com

Hemostemix. Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy...

Never miss Hemostemix.com updates: Start reading the news feed of Hemostemix right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Hemostemix.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Hemostemix

Subscribe to related news

Hemostemix: Your cells, our technology
via totalbiopharma

Valentin Fulga of Hemostemix joined us at Stem Cells & Regenerative Medicine Congress 2014 to present ‘ Hemostemix : Your cells, our technology’ Download the presentation now to learn about Advantages of ACP-01 Ischemic heart disease clinical...
Hemostemix Appoints Hardean E. Achneck, M.D. as Chief Medical Officer
via salesandmarketingnetwork

TORONTO, ON--(Healthcare Sales & Marketing Network) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM) (OTCQX: HMTXF), a clinical-stage autologous cell therapy company, announced today the promotion of Hardean E. Achne... Regenerative...
Global Stem Cell Therapy Market to Witness Highest Growth of 36.52% during the period 2017-2021
via maharashtraherald

Orbis Research Orbis Research Present’s Global Stem Cell Therapy Market 2017-2021 enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. About stem cell therapy Stem cell therapy...
Universities collaborate on drug discovery in stem cell therapies
via dundee

Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better understand the biological processes that could allow the development of new drugs to support tissue regeneration or repair...
Global Regenerative Medicine Market is expected treach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022
via qwtjlive

Regenerative Medicine Market Regenerative medicines hold the ability treplace, repair, and regenerate tissues and organs that are affected due tsome disease, injury, or natural ageing process. These medicines are capable of restoring the functionality...

Hemostemix.com popular pages

Stem Cell Therapy for CLI - Hemostemix

Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases.
Hemostemix - Management

ACP-01 is a Phase 2 clinical candidate that uses a patient’s own cells to restore blood flow to ischemic limbs. Our technology is based on a significant body of clinical data indicating the regenerat...

Hemostemix - Public Filings

Public Filings Public Filings A complete list of public filings is available on the SEDAR (System for Electronic Document Analysis and Retrieval) website.